Related Experiment Video
Updated: Apr 16, 2026

10:10
Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
10.8K
Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations
Pravin Shende1, Yogesh A Kulkarni, R S Gaud
1Department of Chemistry, University of Torino, Italy.
Journal of Pharmaceutical Sciences
|March 11, 2015
Summary
This study assessed the safety of various nanosponges (NS) formulations in rats. Results indicate that these nanosponges are safe for use, showing no significant toxicity in acute or repeated dose studies.
Area of Science:
- Materials Science
- Toxicology
- Biotechnology
Background:
- Nanosponges (NS) are versatile nanomaterials with applications in medicine, agriculture, and environmental remediation.
- Different cross-linking agents and preparation methods influence NS properties and potential applications.
- Evaluating the toxicological profile of novel NS formulations is crucial for their safe development and deployment.
Purpose of the Study:
- To evaluate the acute and repeated dose toxicity of six different nanosponges (NS) formulations (S1-S6) in experimental animals.
- To determine the maximally tolerated dose (MTD) and identify any adverse effects associated with NS administration.
- To assess the safety of NS formulations synthesized using various cross-linking agents and preparation methods.
Main Methods:
- Acute oral toxicity studies were performed on female rats according to OECD guideline 423 (300 and 2000 mg/kg).
- Repeated dose oral toxicity studies were conducted on rats (either sex) at 300 mg/kg/day for 28 days as per OECD guideline 407.
- Animals were monitored for clinical signs, body weight changes, and subjected to necropsy. Haematological and biochemical parameters were analyzed.
Main Results:
- The maximally tolerated dose for all tested nanosponges formulations was found to be 2000 mg/kg.
- No significant changes in general behavior, haematological, or biochemical parameters were observed during acute and repeated dose toxicity studies.
- Repeated administration of nanosponges for 28 days did not induce any notable adverse effects in the experimental animals.
Conclusions:
- The evaluated nanosponges formulations (S1-S6) demonstrate a favorable safety profile in experimental animals.
- These findings suggest that nanosponges are safe for use, supporting their further investigation and application in various fields.
- The study provides essential toxicological data for the safe development and utilization of nanosponges technology.

